Seeking better outcomes for patients
CytRx Corporation is a biopharmaceutical company focused on the discovery and development of new therapeutics to treat patients with high unmet medical needs
CytRx has potential milestone/royalty payments and a subsidiary called Centurion BioPharma
CytRx may receive milestones and royalties from Orphazyme for Arimoclomol
Orphazyme – other indications
Orphazyme – other indications
Orphazyme development programs for arimoclomol
CytRx may receive milestones and royalties from ImmunityBio for aldoxorubicin
CytRx partnered Pipeline with ImmunityBio - aldoxorubicin
